Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin
about
Oxidative Reactivity and Cytotoxic Properties of a Platinum(II) Complex Prepared by Outer-Sphere Amide Bond Coupling.Synthesis, Characterization, and Interaction with Biomolecules of Platinum(II) Complexes with Shikimic Acid-Based Ligands.A novel class of bis- and tris-chelate diam(m)inebis(dicarboxylato)platinum(IV) complexes as potential anticancer prodrugs.Comparative in vitro and in vivo pharmacological investigation of platinum(IV) complexes as novel anticancer drug candidates for oral application.Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.Tumor microenvironment in focus: LA-ICP-MS bioimaging of a preclinical tumor model upon treatment with platinum(IV)-based anticancer agents.Synthetic methods for the preparation of platinum anticancer complexes.Bis- and Tetrakis(carboxylato)platinum(IV) complexes with mixed axial ligands - synthesis, characterization, and cytotoxicity.Theoretical investigations and density functional theory based quantitative structure-activity relationships model for novel cytotoxic platinum(IV) complexes.Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.Diamminetetrakis(carboxylato)platinum(IV) complexes--synthesis, characterization, and cytotoxicity.Novel tetracarboxylatoplatinum(IV) complexes as carboplatin prodrugs.Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.From Synthesis to Biological Impact of Pd (II) Complexes: Synthesis, Characterization, and Antimicrobial and Scavenging ActivityActivation of Platinum(IV) Prodrugs By Motexafin Gadolinium as a Redox Mediator.The impact of whole human blood on the kinetic inertness of platinum(iv) prodrugs - an HPLC-ICP-MS study.Multi-scale imaging of anticancer platinum(iv) compounds in murine tumor and kidney
P2860
Q30443889-3FA0EF80-0A7D-4AA1-93F5-10659DCFBECCQ30607784-E6F34055-01AF-4E42-8FD9-9BD501B0FC82Q35154370-F7010F6A-121F-440D-B399-5CD788CF5512Q35154374-EDD24996-D8CF-4272-918D-94C4B6426322Q35334366-32FFC8A7-4CC9-4F0F-8956-3781429763E8Q35598162-CADA5AE0-1FE0-41DE-98A0-1E73E56D97E0Q37722632-095E6E72-2375-426F-A343-CB78066B2AEBQ38886580-E4386D74-A8B9-4A5F-8AAB-EC74CA5F284FQ39231857-D30892A2-7EAA-4D77-AF5A-9A5C5F2CAAE8Q39235908-2EC1417A-5B4A-4E61-95BF-740EAD3C9E0DQ39278942-40D2F490-8AB4-425C-9E8E-5AA0E67B494EQ39298980-A393F093-2094-448B-A029-2CCACA49BC77Q39372605-AB558656-B35B-4E77-9689-D9D4EF3BD7EDQ39653040-44F532E2-963B-4EF5-A4A3-9DAC4BA2E499Q42096308-E29B1F81-CAB2-482B-96B0-066F597A6C21Q51737285-C939DC22-DA1A-4DEE-923D-BFC4B805A8D7Q57900919-6BAD6142-B1C9-42D4-B396-B27CC9D767CD
P2860
Synthesis and characterization of novel bis(carboxylato)dichloridobis(ethylamine)platinum(IV) complexes with higher cytotoxicity than cisplatin
description
2011 nî lūn-bûn
@nan
2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Synthesis and characterization of novel bis
@nl
Synthesis and characterization ...... er cytotoxicity than cisplatin
@ast
Synthesis and characterization ...... er cytotoxicity than cisplatin
@en
type
label
Synthesis and characterization of novel bis
@nl
Synthesis and characterization ...... er cytotoxicity than cisplatin
@ast
Synthesis and characterization ...... er cytotoxicity than cisplatin
@en
prefLabel
Synthesis and characterization of novel bis
@nl
Synthesis and characterization ...... er cytotoxicity than cisplatin
@ast
Synthesis and characterization ...... er cytotoxicity than cisplatin
@en
P2093
P2860
P50
P1476
Synthesis and characterization ...... er cytotoxicity than cisplatin
@en
P2093
Alexander Roller
Anton A Legin
Markus Galanski
Seied M Valiahdi
P2860
P304
P356
10.1016/J.EJMECH.2011.09.006
P577
2011-09-08T00:00:00Z